Загрузка...
RPGR gene therapy presents challenges in cloning the coding sequence
INTRODUCTION: Currently, there are three Phase I/II clinical trials based on gene therapy ongoing to test different AAV.RPGR or deleted RPGR vectors on patients affected by X-linked retinitis pigmentosa. These three vectors differ in the adeno-associated viral (AAV) vector capsid used, and the codin...
Сохранить в:
| Опубликовано в: : | Expert Opin Biol Ther |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7104355/ https://ncbi.nlm.nih.gov/pubmed/31612744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2020.1680635 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|